In summary, our study utilizing tissue-specific Tsp1 KO mice offers compelling evidence linking platelet-derived TSP1 to the pathogenesis of NAFLD/NASH progression. The gene discussed is THBS1; the disease is metabolic dysfunction-associated steatohepatitis.